Fig. 2.

Characteristics of adults with CHB, based on HBeAg status, HBV therapy and virologic response to therapy, comparing those with HBV monoinfection vs HBV/HIV coinfection from a cross-sectional study in Cape Town, South Africa. A: Proportion of each group testing HBeAg-positive. B: Proportion of monoinfected vs coinfected adults receiving antiviral therapy; C: Proportion of monoinfected vs coinfected adults with HBV DNA viral load suppressed below the limits of quantification (<20 IU/ml) on antiviral therapy. D: HBV/HIV co-infected individuals only, showing proportion who have suppressed HIV and/or HBV viral load below the limit of quantification on antiviral therapy. In all cases, p-values calculated by Fisher's Exact Test, and the number of individuals represented in each group is shown in brackets below the columns.